COMPANY

Leveragen

Location: Woburn, MA · source · Oct 12, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Deal Daiichi Sankyo deal · amount not disclosed · announced Mar 18, 2026 Company release ↗
Source quote
- Mar 18, 2026 · Company release ↗
  “BOSTON, Mass. – March 18, 2026 — Leveragen , a Boston-based biotechnology company developing next-generation in vivo platforms for antibody discovery, today announced a collaboration agreement with Daiichi Sankyo (TSE: 4568) to support research efforts in advanced biologics”
Deal Moderna deal · amount not disclosed · announced Jul 31, 2024 Company release ↗
Source quote
- Jul 31, 2024 · Company release ↗
  “Leveragen and Moderna have entered a research, option and licence agreement to advance the development of various therapeutics”

From the company’s own releases; this list is partial. All raises and deals

Jul 20, 2026 Partnership Partnership / licensing announced Jul 20, 2026. Source: company's own press page. source ↗
Mar 18, 2026 Partnership Partnership / licensing announced Mar 18, 2026. Source: company's own press page. source ↗
Jul 29, 2025 Partnership Partnership / licensing announced Jul 29, 2025. Source: company's own press page. source ↗
Jan 29, 2025 Partnership Partnership / licensing announced Jan 29, 2025. Source: company's own press page. source ↗
Dec 12, 2024 Partnership Partnership / licensing announced Dec 12, 2024. Source: company's own press page. source ↗

Last 2 years.

Jul 20, 2026 Partnership / licensing announced Jul 20, 2026. Source: company's own press page. source ↗
Mar 18, 2026 Partnership / licensing announced Mar 18, 2026. Source: company's own press page. source ↗
Jul 29, 2025 Partnership / licensing announced Jul 29, 2025. Source: company's own press page. source ↗
Jan 29, 2025 Partnership / licensing announced Jan 29, 2025. Source: company's own press page. source ↗
Dec 12, 2024 Partnership / licensing announced Dec 12, 2024. Source: company's own press page. source ↗